These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33747714)

  • 41. Prediction meets causal inference: the role of treatment in clinical prediction models.
    van Geloven N; Swanson SA; Ramspek CL; Luijken K; van Diepen M; Morris TP; Groenwold RHH; van Houwelingen HC; Putter H; le Cessie S
    Eur J Epidemiol; 2020 Jul; 35(7):619-630. PubMed ID: 32445007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. G-estimation of structural nested mean models for competing risks data using pseudo-observations.
    Tanaka S; Brookhart MA; Fine JP
    Biostatistics; 2020 Oct; 21(4):860-875. PubMed ID: 31056651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clarifying causal mediation analysis: Effect identification via three assumptions and five potential outcomes.
    Nguyen TQ; Schmid I; Ogburn EL; Stuart EA
    J Causal Inference; 2022 Jan; 10(1):246-279. PubMed ID: 38720813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bayesian inference for a principal stratum estimand on recurrent events truncated by death.
    Lyu T; Bornkamp B; Mueller-Velten G; Schmidli H
    Biometrics; 2023 Dec; 79(4):3792-3802. PubMed ID: 36647690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Causal inference in survival analysis using pseudo-observations.
    Andersen PK; Syriopoulou E; Parner ET
    Stat Med; 2017 Jul; 36(17):2669-2681. PubMed ID: 28384840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Separable and controlled direct effects for competing events: Estimation of component specific effects on sickness absence.
    Maltzahn NN; Mehlum IS; Gran JM
    Stat Med; 2024 Jul; ():. PubMed ID: 39051609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A practical guide to handling competing events in etiologic time-to-event studies.
    Mansournia MA; Nazemipour M; Etminan M
    Glob Epidemiol; 2022 Dec; 4():100080. PubMed ID: 37637022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Choosing Appropriate Estimands in Clinical Trials.
    Leuchs AK; Zinserling J; Brandt A; Wirtz D; Benda N
    Ther Innov Regul Sci; 2015 Jul; 49(4):584-592. PubMed ID: 30222440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment-competing events in dynamic regimes.
    Johnson BA
    Lifetime Data Anal; 2008 Jun; 14(2):196-215. PubMed ID: 17828622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Causal inference: relating language to event representations and events in the world.
    Wei Y; Knoeferle P
    Front Psychol; 2023; 14():1172928. PubMed ID: 37790219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A taxonomy of estimands for regulatory clinical trials with discontinuations.
    Permutt T
    Stat Med; 2016 Jul; 35(17):2865-75. PubMed ID: 26678026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tying research question and analytical strategy when variables are affected by medication use.
    Choi J; Dekkers OM; le Cessie S
    Pharmacoepidemiol Drug Saf; 2023 Jun; 32(6):661-670. PubMed ID: 36738180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A generalized theory of separable effects in competing event settings.
    Stensrud MJ; Hernán MA; Tchetgen Tchetgen EJ; Robins JM; Didelez V; Young JG
    Lifetime Data Anal; 2021 Oct; 27(4):588-631. PubMed ID: 34468923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis and design of randomised clinical trials involving competing risks endpoints.
    Tai BC; Wee J; Machin D
    Trials; 2011 May; 12():127. PubMed ID: 21595883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An imputation approach using subdistribution weights for deep survival analysis with competing events.
    Gorgi Zadeh S; Behning C; Schmid M
    Sci Rep; 2022 Mar; 12(1):3815. PubMed ID: 35264661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
    Austin PC; Fine JP
    Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. You Can't Drive a Car With Only Three Wheels.
    Banack HR
    Am J Epidemiol; 2019 Sep; 188(9):1682-1685. PubMed ID: 31107525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ESTIMATING POPULATION AVERAGE CAUSAL EFFECTS IN THE PRESENCE OF NON-OVERLAP: THE EFFECT OF NATURAL GAS COMPRESSOR STATION EXPOSURE ON CANCER MORTALITY.
    Nethery RC; Mealli F; Dominici F
    Ann Appl Stat; 2019 Jun; 13(2):1242-1267. PubMed ID: 31346355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimands for overall survival in clinical trials with treatment switching in oncology.
    Manitz J; Kan-Dobrosky N; Buchner H; Casadebaig ML; Degtyarev E; Dey J; Haddad V; Jie F; Martin E; Mo M; Rufibach K; Shentu Y; Stalbovskaya V; Sammi Tang R; Yung G; Zhou J
    Pharm Stat; 2022 Jan; 21(1):150-162. PubMed ID: 34605168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two basic statistical strategies of conducting causal inference in real-world studies.
    Fang Y
    Contemp Clin Trials; 2020 Dec; 99():106193. PubMed ID: 33153972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.